Close
FINDING CURES TOGETHER<sup>SM</sup>

11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research: Biology to Precision Medicine

Friday, Feb. 8, 2019

Welcome and Keynote Session
6:30-8 p.m.

Elaine R. Mardis, Nationwide Children's Hospital, Columbus, Ohio
Shimon Sakaguchi, Osaka University, Osaka, Japan


Opening Reception
8-9:30 p.m.
 

Saturday, Feb. 9, 2019

Continental Breakfast
7-8 a.m.


Plenary Session 1: Tumor Microenvironment
8-9:30 a.m.

Raghu Kalluri, The University of Texas MD Anderson Cancer Center, Houston, Texas
Hideyuki Saya, Keio University School of Medicine, Tokyo, Japan
Mikela Egeblad, Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, New York


Break
9:30-10 a.m.


Plenary Session 2: Cancer Precision Medicine, Prevention, Interception, and Early Detection
10-11:30 a.m.

Nickolas Papadopoulos, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Hiroyuki Mano, National Cancer Center Research Institute, Tokyo, Japan
Geoffrey R. Oxnard, Dana-Farber Cancer Institute, Boston, Massachusetts


Free Time
11:30 a.m.-4 p.m.


Plenary Session 3: Heterogeneity, Clonal Evolution, and Big Data
4-5:30 p.m.

Samuel Aparicio, British Columbia Cancer Agency, Vancouver, Canada
Seong-Jin Kim, Seoul National University, Seoul, South Korea
Mariam Jamal-Hanjani, University College London Cancer Institute, London, United Kingdom


Poster Session A
5:30-7:30 p.m.


Top of page
 

Sunday, Feb. 10, 2019

Continental Breakfast
7-8 a.m.


Plenary Session 4: Metabolism
8-9:30 a.m.

Kei-ichi Nakayama, Kyushu University, Fukuoka, Japan
Lewis C. Cantley, Weill Cornell Medical College, New York- Presbyterian Hospital, New York, New York
Hozumi Motohashi, Tohoku University, Sendai, Japan


Break
9:30-10 a.m.


Plenary Session 5: Epigenetics
10-11:30 a.m.

Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo, Japan
Scott A. Armstrong, Dana-Farber Cancer Institute, Boston, Massachusetts
Reo Maruyama, Japanese Foundation for Cancer Research Cancer Institute, Tokyo, Japan


Free Time
11:30 a.m.-4 p.m.


Plenary Session 6: Immunotherapy
4-5:30 p.m.

Koji Tamada, Yamaguchi University, Yamaguchi, Japan
Ira Mellman, Genentech, South San Francisco, California
Keisuke Kataoka, National Cancer Center Research Institute, Tokyo, Japan


Poster Session B
5:30-7:30 p.m.


Top of page


Monday, Feb. 11, 2019

Continental Breakfast
7-8 a.m.


Plenary Session 7: Microbiome
8-9:30 a.m.

Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas
Masanori Hatakeyama, University of Tokyo, Tokyo, Japan
Sergei Grivennikov, Fox Chase Cancer Center, Philadelphia, Pennsylvania


Break
9:30-10 a.m.


Plenary Session 8: Engineering, Nanotechnology, and Imaging
10-11:30 a.m.

Hiroaki Suga, University of Tokyo, Tokyo, Japan
Daniel A. Heller, Memorial Sloan Kettering Cancer Center, New York, New York
Kei Takahashi, University of Tokyo, Tokyo, Japan


Free Time
11:30 a.m.-4 p.m.


Plenary Session 9: Liquid Biopsy
4-5:30 p.m.

Takahiro Ochiya, Tokyo Medical University, National Cancer Center Research Institute, Tokyo, Japan
Alberto Bardelli, University of Turin - Candiolo Cancer Institute IRCCS, Candiolo, Italy
Koji Ueda, Japanese Foundation for Cancer Research Cancer Institute, Tokyo, Japan


Poster Session C
5:30-7:30 p.m.


Top of page


Tuesday, Feb. 12, 2019

Continental Breakfast
7-8 a.m.

Plenary Session 10: Drug Resistance
8-9:30 a.m.

Seiji Yano, Kanazawa University Cancer Research Institute, Kanazawa, Japan
Alan Ashworth, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California
Ryohei Katayama, Japanese Foundation for Cancer Research Cancer Institute, Tokyo, Japan


Break
9:30-10 a.m.


Plenary Session 11: Novel Targets and Drug Discovery
10-11:30 a.m.

Kevan Michael Shokat, University of California San Francisco and Howard Hughes Medical Institute, San Francisco, California
Hiroyuki Seimiya, Japanese Foundation for Cancer Research Cancer Institute, Tokyo, Japan
Cigall Kadoch, Dana-Farber Cancer Institute, Boston, Massachusetts


Free Time
11:30 a.m.-4 p.m.


Plenary Session 12: Clinical Research and Clinical Trials
4-5:30 p.m.

Riccardo Dalla-Favera, Columbia University Institute for Cancer Genetics, New York, New York
Atsushi Hirao, Kanazawa University Cancer Research Institute, Kanazawa, Japan
Dejan Juric, Massachusetts General Hospital Cancer Center, Boston, Massachusetts


Poster Session D
5:30-7:30 p.m.